CHONGQING IMED BIOSCIENCE CO LTD

Overview

CHONGQING IMED BIOSCIENCE CO LTD is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering RECOMBINANT KEXIN PROTEASE; RECOMBINANT LYSYL ENDOPEPTIDASE.

API / Drug Master Files

CHONGQING IMED BIOSCIENCE CO LTD holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• RECOMBINANT LYSYL ENDOPEPTIDASEActive2023-12-12
• RECOMBINANT KEXIN PROTEASEActive2023-08-21

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHONGQING IMED BIOSCIENCE CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.